VITAFORT INTERNATIONAL CORP
PRE 14A, 1997-05-09
BAKERY PRODUCTS
Previous: POLARIS AIRCRAFT INCOME FUND VI, 10-Q, 1997-05-09
Next: JONES GROWTH PARTNERS II L P, DEF 14A, 1997-05-09



<PAGE>
 
================================================================================
 
                                 SCHEDULE 14A
                                (Rule 14a-101)
                    INFORMATION REQUIRED IN PROXY STATEMENT
                           SCHEDULE 14A INFORMATION
          Proxy Statement Pursuant to Section 14(a) of the Securities
                    Exchange Act of 1934 (Amendment No.  )
        
Filed by the Registrant [X]

Filed by a Party other than the Registrant [_] 

Check the appropriate box:

[X]  Preliminary Proxy Statement        [_]  Confidential, for Use of the 
                                             Commission Only (as permitted by
                                             Rule 14a-6(e)(2))
[_]  Definitive Proxy Statement 

[_]  Definitive Additional Materials 

[_]  Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

                      Vitafort International Corporation
- --------------------------------------------------------------------------------
               (Name of Registrant as Specified In Its Charter)

                      Vitafort International Corporation
- --------------------------------------------------------------------------------
   (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

   
Payment of Filing Fee (Check the appropriate box):

[_]  No fee required.

[_]  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

   
     (1) Title of each class of securities to which transaction applies:

     -------------------------------------------------------------------------


     (2) Aggregate number of securities to which transaction applies:

     -------------------------------------------------------------------------


     (3) Per unit price or other underlying value of transaction computed
         pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
         the filing fee is calculated and state how it was determined):

     -------------------------------------------------------------------------
      

     (4) Proposed maximum aggregate value of transaction:

     -------------------------------------------------------------------------


     (5) Total fee paid:

     -------------------------------------------------------------------------

[_]  Fee paid previously with preliminary materials.
     
[_]  Check box if any part of the fee is offset as provided by Exchange
     Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
     was paid previously. Identify the previous filing by registration statement
     number, or the Form or Schedule and the date of its filing.
     
     (1) Amount Previously Paid:
 
     -------------------------------------------------------------------------


     (2) Form, Schedule or Registration Statement No.:

     -------------------------------------------------------------------------


     (3) Filing Party:
      
     -------------------------------------------------------------------------


     (4) Date Filed:

     -------------------------------------------------------------------------

Notes:



<PAGE>
 
                  NOTICE OF ACTION OF STOCKHOLDERS BY WRITTEN
                    CONSENT IN LIEU OF STOCKHOLDERS MEETING

Dear Fellow Stockholders:

     On behalf of the Board of Directors and Management of Vitafort
International Corporation (the "Company"), I urge you to consider and act upon
the following proposal which the Board of Directors recommends that stockholders
approve by written Consent in Lieu of a Stockholder's Meeting. To amend the
Certificate of Incorporation of the Company to increase the number of authorized
shares of Common Stock from 9,000,000 to 30,000,000.

     Only stockholders of record at the close of business on June 2, 1997 (the
"Record Date"), will be requested to give their consent. To be effective,
executed consents must signed dated and received at he office of the Company or
its Transfer Agent. While there is no specific deadline for the giving of
consents, the Company does not intend to seek consents for a period in excess of
sixty days from the first use of this Consent Statement. Any Stockholder who
signs a written consent may revoke it by a written revocation delivered to the
President of the Company at its offices on or before the such time as the
consents of the holders of a majority of the issued and outstanding shares has
been received by the Company. There will not be a meeting at which Stockholders
may vote in person. If the proposed action is approved by the written consent of
the holders of the requisite number of shares of Common Stock, then an
Information Statement advising all Stockholders of such action will be
distributed to all Stockholders of record. The proposed amendment will not be
effected until at least twenty (20) days from the mailing of such Information
Statement to all Stockholders of record. The address of the Company is: Vitafort
International Corporation; Suite 480; 1800 Avenue of the Stars; Los Angeles;
California 90067.

                          BY ORDER OF THE BOARD OF DIRECTORS

                          MARK BEYCHOK,
                          PRESIDENT AND CHIEF EXECUTIVE OFFICER
                          June 2, 1997

YOUR CONSENT IS IMPORTANT.  YOU ARE URGED TO DATE, SIGN AND RETURN YOUR CONSENT
PROMPTLY SO THAT YOUR SHARES MAY BE VOTED IN ACCORDANCE WITH YOUR WISHES AND IN
ORDER THAT THE APPROVAL OF THE PROPOSED CORPORATE ACTIONS BY THE CONSENT OF THE
MAJORITY OF THE ISSUED AND OUTSTANDING SHARES MAY BE ASSURED.  THE PROMPT RETURN
OF YOU CONSENT WILL ALSO AID THE COMPANY IN REDUCING THE EXPENSE OF CONSENT
SOLICITATION, THE GIVING OF SUCH CONSENT DOES NOT AFFECT YOUR RIGHT TO CHANGE
YOUR VOTE BY REVOKING YOUR CONSENTS IN A SUBSEQUENT WRITING IN ADVANCE OF THE
DATE WHEN THE REQUISITE NUMBER OF CONSENTS HAS BEEN RECEIVED BY THE COMPANY.
<PAGE>
 
                       VITAFORT INTERNATIONAL CORPORATION
                      1800 AVENUE OF THE STARS, SUITE 480
                         LOS ANGELES, CALIFORNIA 90067


                               CONSENT STATEMENT


     Stockholder Consents are being solicited by the Board of Directors of
Vitafort International Corporation (the "Company") for use in connection with
the taking of an action of Stockholders by Written Consent in Lieu of a Meeting.
This Consent Statement and form of Consent are being sent to all stockholders on
or about June 2,1997. If the proposal is adopted, an Information Statement with
respect to the approved action will be mailed to all stockholders of record and
no action will be taken on any approved proposal until at least twenty days
after the date the Information Statement is mailed.

     As of May 31, 1997, there were ________ outstanding shares of Common Stock,
which is the only outstanding class of securities of the Company entitled to
give consent to this proposed action. Each outstanding share of Common Stock is
entitled to one vote on the matter to be voted upon.

     Properly executed Consents will be voted in accordance with the
instructions indicated in such Consents. If no instructions are indicated, such
Consents will be voted in favor of the proposal to amend the Company's
Certificate of Incorporation to increase the number of authorized shares of
Common Stock from 9,000,000 to 30,000,000 shares.

     Any Consents given pursuant to this solicitation may be revoked at any time
prior to the Company receiving Consents from the holders of a majority of the
issued and outstanding shares of Common Stock, by delivery to the President of
the Company of a written notice of revocation.

                                       2
<PAGE>
 
                             PRINCIPAL STOCKHOLDERS

     The following table sets forth certain information regarding the Company's
 Common Stock beneficially owned on April 30, 1997 by (i) each person who is
 known by the Company to own beneficially or exercise voting or dispositive
 control over 5% or more of the Company's Common Stock, (ii) each of the
 Company's Directors and (iii) all executive officers and Directors as a group.
 Except as otherwise indicated, all stockholders have sole voting and investment
 power with respect to the shares listed as beneficially owned by them, subject
 to the rights of spouses under applicable community property laws:
 
<TABLE>
<CAPTION>

 Name and Address                              Number of Shares
 of Beneficial Owner                           of Common Stock                             Percentage of
 Identity of Group                             Beneficially Owned                       Beneficial Ownership
 -----------------                             ------------------                       --------------------
<S>                                            <C>                                      <C>

 Mark Beychok (1)                                    565,572 (2)                                %

 Donald Wohl(1)                                      200,000 (3)                                %

 Paul S. Hermis                                      100,000 (4)
 15510 Sunset Boulevard - No. 303
 Pacific Palisades, California 90272

 Benjamin Tabatchnick                                100,000 (4)
 Tabatchnick Fine Foods
 1230 Hamilton Street
 Somerset, New Jersey 08873

 John Coppolino (1)                                   57,666 (5)


 ALL DIRECTORS AND
 OFFICERS AS A GROUP
 (5 PERSONS)                                       1,023,238 (2)(3)(4) and (5)             _____%
</TABLE>

(1)  The Address of these persons is Suite 480, 1800 Avenue of the Stars, Los
Angeles, California 90067, except for Donald Wohl whose address is in Suite 1114
in such building.

(2)  Includes (i) 62,500 shares underlying a currently exercisable option with
an exercise price of $3.00 per share which expires on December 16, 2000;
(ii) 15,000 shares underlying a currently exercisable option with an
exercise price of $3.00 per share which expires on September 29, 1998;
(iii) 100,000 shares underlying a currently exercisable option with an
exercise price of $5.00 per share which expires on November 15, 1998; (iv)
100,000 shares underlying the currently exercisable portion of a stock
option, expiring December 16, 2000, which has an exercise price of $3.00
per share (but does not include 50,000 shares underlying such option which
are not currently exercisable); (v) 9,547 shares underlying a currently
exercisable option with an exercise price of $4.50 per share which expires
January 7, 1998;  (vi) 9,547 shares underlying a currently exercisable
option with an exercise price of $6.00 per share which expires July 7,
1998; (v) includes 134,375 shares underlying the currently exercisable
portion of a stock option, expiring December 16, 2000, which has an
exercise price of $3.00 per share (but does not include 134,375 shares
underlying such stock option which are not currently exercisable and
becomes exercisable on January 1, 1998, subject to the Company meeting
certain performance criteria), and includes 100,000 shares underlying a
currently exercisable option with an exercise price of $.875 which expires
December 31, 2002.

                                       3
<PAGE>
 
(3)  Includes 100,000 shares underlying the currently exercisable portion a
stock option, expiring December 16, 2000, which has an exercise price of
$3.00 per share (but does not include 50,000 shares underlying such stock
option which are not currently exercisable).  Includes 100,000 shares
underlying a currently exercisable stock option, expiring December 31,
2002, which has an exercise price of $.875.  Does not include any shares
owned by ATCOLP Partners, L.P., a California limited partnership in which
Mr. Wohl is the general partner.  In addition to such shares as it
presently owns, ATCOLP Partners, L.P. will acquire from 200,000 to 400,000
options at $.01 in connection with a loan it has made to the Company to
fund certain legal expenses.

(4)  Each of Messrs. Tabatchnick and Hermis holds a currently exercisable option
for the purchase of 50,000 shares at $.875 and has entered into a
consulting agreement which provides for the issuance of 50,000 shares,
subject to forfeiture if certain performance standards relating to sales
into certain markets are not met.

(5)  Includes (i) 56,250 shares underlying a currently exercisable option with
an exercise price of $3.00 per share, which expires on December 16, 2000,
(but does not include 112,500 shares underlying such option which are not
currently exercisable), (ii) includes 1,375 shares underlying a currently
exercisable option with an exercise price of $4.50, which expires January
7, 1998; and (iii) includes 1,375 shares underlying a currently exercisable
option with an exercise price of $6.00, which expires on July 7, 1998.



                                    PROPOSAL
                                    --------

          TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK WHICH THE
          ----------------------------------------------------------
            COMPANY HAS AUTHORITY TO ISSUE FROM 9,000,000 SHARES TO
            -------------------------------------------------------
                              30,000,000 SHARES.
                              ------------------

     The Company's presently authorized capital consists of 9,000,000 shares of
Common Stock, par value $.0001 per share, and 500,000 shares of Preferred Stock,
par value $.01 per share.  The Board of Directors has authorized, subject to
shareholder approval, an amendment to Article Fourth of the Company's
Certificate of Incorporation to increase the numbers of authorized shares of
Common Stock from 9,000,000 to 30,000,000.  This amendment will not effect any
changes in the presently authorized or outstanding shares of Common Stock or
Preferred Stock.

Reasons for the Proposed Amendment
- ----------------------------------

     As of May 31, 1997, the Company had __________ shares of Common Stock
issued and outstanding.  In addition, approximately _______________ shares of
common stock are reserved for issuance upon exercise of options and warrants and
approximately ________ shares issuable upon conversion of issued and outstanding
shares of Series B, Series C and 1997 Series A Preferred Stock (before giving
effect to any anti-dilution provisions of such options, warrants and preferred
shares).  While only a portion of the options and warrants are currently
exercisable it is obvious, that the Company requires additional authorized
shares of Common Stock to meet its current and reasonably anticipated
commitments.

                                       4
<PAGE>
 
     The additional Common Stock authorized by the amendment could also be
issued publicly or privately in connection with future financings or
acquisitions.  At this time, the Company is not seeking an underwriter and has
no plans to underwrite a public offering of Common Stock.  The Company is not
currently actively engaged in any merger or acquisition negotiations.

     Because of the number of issued and outstanding shares of Common Stock and
present reservations, the Company currently has an insufficient number of
authorized shares of Common Stock available for issuance to meet its current
commitments.  Furthermore it can not initiate or consummate any transaction
involving the issuance of Common Stock (or securities exercisable for or
convertible into Common Stock), public or private, and its future ability to do
so is conditioned, among other things, upon approval by the Company's
shareholders of the proposed amendment to the Company's Certificate of
Incorporation to increase the number of authorized shares of Common Stock
available for issuance.  The Company has agreed with the holder of the 1997
Series A Preferred Stock that it would seek this authorization to increase the
number of authorized shares of Common Stock.

     Whether or not shareholders approve the proposed amendment to the Company's
Certificate of Incorporation, there can be no assurance that any future
transactions or offerings of the Company's securities, public or private, will
be consummated.  If the proposed amendment is approved, the Company does not
intend to solicit further authorization from stockholders for the issuance of
the Common Stock prior to such issuance, subject to the provisions of the
Delaware General Corporation Law.  The Board of Directors believes that prudent
business planning suggests that the Company authorize the additional 21,000,000
shares of Common Stock at this time.

     Although the Board of Directors has no present intention of doing so, the
Common Stock could also be used by the directors to defeat or delay a hostile
takeover.  Faced with an actual or proposed hostile takeover, the directors
could issue a significant number of shares of Common Stock to a friendly party
in a private transaction such that the Company may become a less attractive
acquisition for a hostile party.  The directors are not aware of any current
proposals by any party to acquire control of the Company and does not presently
contemplate recommending the adoption of further amendments to the Company's
Certificate of Incorporation which would affect the ability of third parties to
take over or change control of the Company.

     The foregoing summary description of the proposed amendment to the
Company's Certificate of Incorporation is not intended to be complete and is
qualified in its entirety by reference to the complete text of the proposed
amendment attached to this Consent Statement as Exhibit "A."

                                       5
<PAGE>
 
Vote Required for Approval
- --------------------------

     Approval of this proposal requires the affirmative vote of a majority of
the outstanding shares of Common Stock of the Company.  If the amendment is not
approved, the authorized Common Stock will continue to be 9,000,000 shares.

BOARD OF DIRECTOR'S RECOMMENDATION
- ----------------------------------

     The Board of Directors believes that the proposal to amend the Certificate
of Incorporation to authorize additional shares of Common Stock is in the best
interests of the Company.  ACCORDINGLY, THE BOARD RECOMMENDS THAT STOCKHOLDERS
VOTE IN FAVOR OF THE PROPOSED AMENDMENT OF THE COMPANY'S CERTIFICATE OF
INCORPORATION.

                                       6
<PAGE>
 
                                 OTHER MATTERS

                     SUBMISSION OF SHAREHOLDER'S PROPOSALS

     Shareholders are advised that any proposals they may wish to submit for
presentation at next year's Annual Meeting for inclusion in the Company's proxy
statement and form of proxy for such meeting must be received by the Company on
or before February 1, 1998.

                                  FORM 10-KSB

     UPON THE WRITTEN REQUEST OF A RECORD HOLDER OR BENEFICIAL OWNER OF COMMON
STOCK ENTITLED TO VOTE AT A MEETING, THE COMPANY WILL PROVIDE WITHOUT CHARGE A
COPY OF ITS ANNUAL REPORT ON FORM 10-KSB, INCLUDING THE FINANCIAL STATEMENTS AND
FINANCIAL STATEMENT SCHEDULES FILED WITH THE SECURITIES AND EXCHANGE COMMISSION
FOR THE YEAR ENDED DECEMBER 31, 1996.  REQUESTS SHOULD BE MAILED TO MARK
BEYCHOK, VITAFORT INTERNATIONAL CORPORATION, SUITE 480, 1800 AVENUE OF THE
STARS, LOS ANGELES, CALIFORNIA 90067.

                            SOLICITATION OF CONSENTS

     The cost of solicitation of Consents in the accompanying form has been or
will be borne by the Company.  In addition to solicitation by mail, arrangements
may be made with brokerage houses and other custodians, nominees and fiduciaries
to send consents and consent solicitation material to their principals, and the
Company may reimburse them for any attendant expenses.

     In order to ensure the adoption of the proposed action, all stockholders
who receive this Consent Statement are requested to sign and return promptly the
enclosed Consent in the postage paid envelope provided for that purpose.

                       BY ORDER OF THE BOARD OF DIRECTORS

                       Mark Beychok, President and
                       Chief Executive Officer

                       June  , 1997

                                       7

<PAGE>
 
EXHIBIT A

                            CERTIFICATE OF AMENDMENT
                                     OF THE
                          CERTIFICATE OF INCORPORATION
                                       OF
                       VITAFORT INTERNATIONAL CORPORATION

                            Pursuant to Section 242
                         of the General Corporation Law
                            of the State of Delaware

          VITAFORT INTERNATIONAL CORPORATION, a Delaware
          corporation (the "Corporation"), hereby certifies as follows:

           FIRST: The amendment to the Certificate of Incorporation to be
effected hereby is as follows:

          Paragraph 4 of the Certificate of Incorporation, relating to the
authorized capital stock of the Corporation, is hereby amended to read as
follows:

     4.  The total number of shares of all classes of stock that the Corporation
     shall have authority to issue is 30,500,000, of which 500,000 shall be
     Preferred Stock, par value $.01 per share and 30,000,000 shall be Common
     Stock, par value $.0001 per share ("Common Stock"), and the voting power,
     designations, preferences and relative participating option or other
     special qualifications, limitations or restrictions thereof are set forth
     hereinafter:

          1.  Preferred Stock
              ---------------

               (a) The Preferred Stock may be issued in one or more series, each
               of which shall be distinctively designated, shall rank equally
               and shall be identical in all respects except as otherwise
               provided in subsection 1(b) of this Section 4.

               (b) Authority is hereby vested in the Board of Directors to issue
               from time to time the Preferred Stock of any series and to state
               in the resolution or resolutions providing for the issuance of
               shares of any series the voting powers, if any, designations,
               preferences and relative, participating, optional or other
               special rights, and the qualifications, limitations or
               restrictions of such series to the full extent now or hereafter
               permitted by the law of the State of Delaware in respect of the
               matters set forth in the following clauses (i) to (viii)
               inclusive;

                                      A-1
<PAGE>
 
               (i) the number of shares to constitute such series, and the
               distinctive designations thereof;

               (ii) the voting powers, full or limited, if any, of such series;

               (iii) the rate of dividends payable on shares of such series, the
               conditions on which and the times when such dividends are
               payable, the preference to, or the relation to, the payment of
               the dividends payable on any other class, classes or series of
               stock, whether cumulative or non-cumulative and, if cumulative,
               the date from which dividends on shares of such series shall be
               cumulative;

               (iv) the redemption price or prices, if any, and the terms and
               conditions on which shares of such series shall be redeemable;

               (v) the requirement of any sinking fund or funds to be applied to
               the purchase or redemption of shares of such series and, if so,
               the amount of such fund or funds and the manner of application;

               (vi) the rights of shares of such series upon the liquidation,
               dissolution or winding up of, or upon any distribution of the
               assets of, the Corporation;

               (vii) the rights, if any, of the holders of shares of such series
               to convert such shares into, or to exchange such shares for,
               shares of any other class, classes or series of stock and the
               price or prices or the rates of exchange and the adjustments at
               which such shares shall be convertible or exchangeable, and any
               other terms and conditions of such conversion or exchange;

               (viii) any other preferences and relative, participating,
               optional or other special rights of shares of such series, and
               qualifications, limitations or restrictions including, without
               limitation, any restriction on an increase in the number of
               shares of any series theretofore authorized and any
               qualifications, limitations or restrictions of rights or powers
               to which shares of any future series shall be subject.

               (c) The number of authorized shares of Preferred Stock may be
               increased or decreased by the affirmative vote of the holders of
               a majority of the votes of all classes of voting securities of
               the Corporation without a class vote of the Preferred Stock, or
               any series thereof, except as otherwise provided in the
               resolution or resolutions fixing the voting rights of any series
               of the Preferred Stock.

                                      A-2
<PAGE>
 
               2. Common Stock
                  ------------

               (a) After the requirements with respect to preferential dividends
               on the Preferred Stock (fixed in accordance with the provisions
               of Paragraph 1 of this Section 4), if any, shall have been met
               and after the corporation shall have complied with all the
               requirements, if any, with respect to the setting aside of same
               as sinking funds or redemption or purchase accounts (fixed in
               accordance with the provisions of Paragraph 1 of this Section 4),
               and subject further to any other conditions which may be fixed in
               accordance with the provisions of Paragraph 1 of this Section 4,
               then and not otherwise the holders of Common Stock shall be
               entitled to receive such dividends as may be declared from time
               to time by the Board of Directors.

               (b) After distribution in full of the preferential amount (fixed
               in accordance with the Provisions of Paragraph 1 of this Section
               4), if any, to be distributed to the holders of Preferred Stock
               in the event of the voluntary or involuntary liquidation,
               distribution or sale of assets, dissolution or winding-up of the
               Corporation, the holders of Common Stock shall, subject to the
               rights, if any, of the holders of Preferred Stock to participate
               therein (fixed in accordance with the provisions of Paragraph 1
               of this Section 4) be entitled to receive all the remaining
               assets of the Corporation, tangible and intangible, of whatever
               kind available for distribution to stockholders ratably in
               proportion to the number of shares of Common Stock held by them
               respectively.

               (c) Except as may otherwise be required by law or by the
               provisions of such resolution or resolutions as may be adopted by
               the Board of Directors pursuant to Paragraph 1 of this Section 4,
               each holder of Common Stock shall have one vote in respect of
               each share of Common Stock held by him on all matters voted upon
               by the stockholders.

          3.   OTHER PROVISIONS RELATED TO SHARES OF STOCK:
               ------------------------------------------- 

               (a) No holder of any of the shares of any class or series of
               stock or of options, warrants or other rights to purchase shares
               of any class or series of stock or of other securities of the
               Corporation shall have any preemptive right to purchase or
               subscribe for any unissued stock of any class or series or any
               additional shares of any class or series to be issued by reason
               of any increase of the authorized capital stock of the
               Corporation of any class or series, or bonds, certificates of
               indebtedness, debentures or other securities convertible into or
               exchangeable for stock of the Corporation of any class or series,
               or carrying any right to purchase stock of any class or series,
               but such unissued

                                      A-3
<PAGE>
 
               stock, additional authorized issue of shares of any class or
               series of stock or securities convertible into or exchangeable
               for stock, or carrying any right to purchase stock, may be issued
               and disposed of pursuant to resolution of the Board of Directors
               to such persons, firms, corporations or associations, whether
               such holders or others, and upon such terms as may be deemed
               advisable by the Board of Directors in the exercise of its sole
               discretion.

               (b) The powers and rights of Common Stock shall be subordinated
               to the powers, preferences and rights of the holders of Preferred
               Stock. The relative powers, preferences and rights of each series
               of Preferred Stock in relation to the powers, preferences and
               rights of each other series of Preferred Stock shall, in each
               case, be as fixed from time to time by the Board of Directors in
               the resolution or resolutions adopted pursuant to authority
               granted in Paragraph I of this Section 4 and the consent, by
               Class or series, vote or otherwise, of the holders of such of the
               series of are from time to time outstanding Preferred Stock as
               for the issuance by the Board of shall not be required Directors
               of any other series of rights of such other series shall be fixed
               by the Board of Directors as senior to, or on a parity with, the
               powers, preferences and rights of such outstanding series, or any
               of them; provided, however, that the Board of Directors may
               provide in the resolution or resolutions as to any series of
               Preferred Stock adopted pursuant to Paragraph 1 of this 4 Section
               4 that the consent of the holders of a majority (or such greater
               proportion as shall be therein fixed) of the outstanding shares
               of such series voting thereon shall be required for the issuance
               of any or all other series of Preferred Stock.

               (c) subject to the provisions of subparagraph (b) of this
               Paragraph 3 of this Section 4, shares of any series of Preferred
               Stock may be authorized or issued from time to time as the Board
               of Directors in its sole discretion shall determine and on such
               terms and for such consideration as shall be fixed by the Board
               of Directors in its sole discretion.

               (d) Shares of Common stock may be issued from time to time as the
               Board of Directors in its sole discretion shall determine and on
               such terms and for such consideration as shall be fixed by the
               board of Directors in its sole discretion.

               (e) The authorized number of shares of Common Stock and of
               Preferred Stock Preferred Stock may be increased or decreased
               from time to time by the affirmative vote of the holders of a
               majority of the outstanding shares of Common Stock and Preferred
               Stock of the corporation entitled to vote thereon.

                                      A-4
<PAGE>
 
     SECOND: The foregoing amendment to the Certificate of Incorporation of the
Corporation was duly adopted by the holders of at least a majority of the
outstanding shares entitled to vote by their giving written consent thereto in
accordance with Section 242 of the Delaware General Corporation Law

     IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Amendment to be signed by its President and its Assistant Secretary this ______
day of _______, 1997.

                                  VITAFORT INTERNATIONAL CORPORATION



                                  -------------------------------------
                                  Mark Beychok, President



                                  -------------------------------------
                                  Frank J. Hariton, Assistant Secretary

                                      A-5
<PAGE>
 
                     WRITTEN CONSENT OF THE SHAREHOLDERS OF
                       VITAFORT INTERNATIONAL CORPORATION

     Unless otherwise indicated below, the undersigned, being a stockholder of
record of shares of common stock of Vitafort International Corporation (the
"Company"), and in the aggregate the holders of record of a majority of the
issued and outstanding shares of common stock of the Company, do(es) hereby
consent in writing to the adoption of the following resolution and to the taking
of all action required or permitted thereby:

              RESOLVED, that the Certificate of Incorporation of Vitafort
          International Corporation be amended to increase the number of
          shares of common stock which it is authorized to issue from
          9,000,000 shares to 30,000,000 shares.

      /  /  CONSENTS        /  /  DOES NOT CONSENT         /  /  ABSTAINS
 
        This written consent may be signed in counterparts all of which taken
   together shall constitute the consent of the holders of a majority of the
   issued and outstanding shares of common stock of Vitafort International
   Corporation.


                                    -------------------------------------------
                                                   Sign Name 


                                    -------------------------------------------
                                         Joint Owner signs (if applicable)


                                    -------------------------------------------
                                                  Number of Shares


                                    -------------------------------------------
                                                        Date


   PLEASE SIGN YOUR NAME(S) EXACTLY AS IT (THEY) APPEAR ON YOUR STOCK
   CERTIFICATES, IN THE CASE OF JOINT OWNERSHIP, BOTH OWNERS MUST SIGN. IF NO
   INDICATION IS MADE, THE CONSENT WILL BE COUNTED AS BEING IN FAVOR OF THE
   PROPOSAL.

   SHAREHOLDERS MAY ALSO WITHHOLD THEIR CONSENT BY NOT SIGNING AND NOT RETURNING
   THIS CONSENT


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission